U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 42

1.
Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy
Mark Roschewski, Daniel J. Hodson
Haematologica. 2024 Feb 1; 109(2): 388–400. Published online 2023 Sep 14. doi: 10.3324/haematol.2021.278613
PMCID:
PMC10828633
ArticlePDF–2.0M
2.
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors
Maria Eugénia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec, Robin Droit, Wan Ching Lim, Antonin Marchais, Jerome Salmon, Sarah Cherkaoui, Raphael J. Morscher, Anouchka Laurent, Sébastien Malinge, Thomas Mercher, Séverine Tabone-Eglinger, Isabelle Goddard, Francoise Pflumio, Julien Calvo, Francoise Redini, Natacha Entz-Werlé, Aroa Soriano, Alberto Villanueva, Stefano Cairo, Pascal Chastagner, Massimo Moro, Cormac Owens, Michela Casanova, Raquel Hladun-Alvaro, Pablo Berlanga, Estelle Daudigeos-Dubus, Philippe Dessen, Laurence Zitvogel, Ludovic Lacroix, Gaelle Pierron, Olivier Delattre, Gudrun Schleiermacher, Didier Surdez, Birgit Geoerger
Commun Biol. 2023; 6: 949. Published online 2023 Sep 18. doi: 10.1038/s42003-023-05320-0
PMCID:
PMC10507044
ArticlePDF–2.7M
3.
Single‐cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug‐resistance mechanisms of recurrent glioblastoma
Haibin Wu, Chengcheng Guo, Chaoye Wang, Jiang Xu, Suyue Zheng, Jian Duan, Yiyun Li, Hongming Bai, Qiuyan Xu, Fangling Ning, Feng Wang, Qunying Yang
Cancer Sci. 2023 Jun; 114(6): 2609–2621. Published online 2023 Mar 10. doi: 10.1111/cas.15773
PMCID:
PMC10236634
ArticlePDF–13M
4.
The proteomic landscape of Glioblastoma recurrence reveals novel and targetable immunoregulatory drivers
Nazanin Tatari, Shahbaz Khan, Julie Livingstone, Kui Zhai, Dillon Mckenna, Vladimir Ignatchenko, Chirayu Chokshi, William D Gwynne, Manoj Singh, Spencer Revill, Nicholas Mikolajewicz, Chenghao Zhu, Jennifer Chan, Cynthia Hawkins, Jian-Qiang Lu, John P. Provias, Kjetil Ask, Sorana Morrissy, Samuel Brown, Tobias Weiss, Michael Weller, Hong Han, Jeffrey N Greenspoon, Jason Moffat, Chitra Venugopal, Paul C. Boutros, Sheila K. Singh, Thomas Kislinger
Acta Neuropathol. Author manuscript; available in PMC 2023 May 16.
Published in final edited form as: Acta Neuropathol. 2022 Dec; 144(6): 1127–1142. Published online 2022 Sep 30. doi: 10.1007/s00401-022-02506-4
PMCID:
PMC10187978
ArticlePDF–1.3M
5.
Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases
Christina A. Von Roemeling, Bently P. Doonan, Kelena Klippel, Daniel Schultz, Lan Hoang-Minh, Vrunda Trivedi, Chenglong Li, Rylynn A. Russell, Raju S. Kanumuri, Abhisheak Sharma, Han W. Tun, Duane A. Mitchell
Clin Cancer Res. 2023 May 1; 29(9): 1751–1762. Published online 2023 Feb 7. doi: 10.1158/1078-0432.CCR-22-1682
PMCID:
PMC10150246
ArticlePDF–10M
6.
Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma
Yoonhee Nam, Harim Koo, Yingxi Yang, Sang Shin, Zhihan Zhu, Donggeon Kim, Hee Jin Cho, Quanhua Mu, Seung Won Choi, Jason K. Sa, Yun Jee Seo, Yejin Kim, Kyoungmin Lee, Jeong-Woo Oh, Yong-Jun Kwon, Woong-Yang Park, Doo-Sik Kong, Ho Jun Seol, Jung-Il Lee, Chul-Kee Park, Hye Won Lee, Yeup Yoon, Jiguang Wang
Genome Med. 2023; 15: 16. Published online 2023 Mar 13. doi: 10.1186/s13073-023-01165-8
PMCID:
PMC10010007
ArticlePDF–2.3M
7.
Comprehensive Assessment of Secreted Immuno-Modulatory Cytokines by Serum-Differentiated and Stem-like Glioblastoma Cells Reveals Distinct Differences between Glioblastoma Phenotypes
Laverne D. Robilliard, Jane Yu, Akshata Anchan, Graeme Finlay, Catherine E. Angel, E Scott Graham
Int J Mol Sci. 2022 Nov; 23(22): 14164. Published online 2022 Nov 16. doi: 10.3390/ijms232214164
PMCID:
PMC9692434
ArticlePDF–5.7M
8.
Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study
N. Girard, S. Galland-Girodet, V. Avrillon, B. Besse, M. Duruisseaux, J. Cadranel, J. Otto, A. Prevost, B. Roch, J. Bennouna, K. Bouledrak, M. Coudurier, T. Egenod, R. Lamy, C. Ricordel, D. Moro-Sibilot, L. Odier, J. Tillon-Strozyk, G. Zalcman, P. Missy, V. Westeel, S. Baldacci
ESMO Open. 2022 Apr; 7(2): 100418. Published online 2022 Feb 26. doi: 10.1016/j.esmoop.2022.100418
PMCID:
PMC9058895
ArticlePDF–351K
9.
Abnormal Schwannoma-like Growth of multiple, multifocal BRAF V600E-positive Glioblastoma in the Interior Acoustic Canal with Leptomeningeal Infiltration: a case report
Roopa Jayarama-Naidu, Evelyn Gallus
J Med Case Rep. 2022; 16: 50. Published online 2022 Feb 8. doi: 10.1186/s13256-022-03272-3
PMCID:
PMC8822757
ArticlePDF–1.3M
10.
A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors
Stefano Di Giulio, Valeria Colicchia, Fabio Pastorino, Flaminia Pedretti, Francesca Fabretti, Vittoria Nicolis di Robilant, Valentina Ramponi, Giorgia Scafetta, Marta Moretti, Valerio Licursi, Francesca Belardinilli, Giovanna Peruzzi, Paola Infante, Bianca Maria Goffredo, Anna Coppa, Gianluca Canettieri, Armando Bartolazzi, Mirco Ponzoni, Giuseppe Giannini, Marialaura Petroni
Oncogene. 2021; 40(43): 6143–6152. Published online 2021 Sep 10. doi: 10.1038/s41388-021-02003-0
PMCID:
PMC8553625
ArticlePDF–4.7M
11.
Perspective of mesenchymal transformation in glioblastoma
Yona Kim, Frederick S. Varn, Sung-Hye Park, Byung Woo Yoon, Hye Ran Park, Charles Lee, Roel G. W. Verhaak, Sun Ha Paek
Acta Neuropathol Commun. 2021; 9: 50. Published online 2021 Mar 24. doi: 10.1186/s40478-021-01151-4
PMCID:
PMC7992784
ArticlePDF–3.8M
12.
Clinical significance of checkpoint regulator “Programmed death ligand-1 (PD-L1)” expression in meningioma: review of the current status
Shirin Karimi, Sheila Mansouri, Farshad Nassiri, Severa Bunda, Olivia Singh, Priscilla K. Brastianos, Ian F. Dunn, Gelareh Zadeh
J Neurooncol. 2021; 151(3): 443–449. Published online 2021 Feb 21. doi: 10.1007/s11060-020-03584-8
PMCID:
PMC7897616
ArticlePDF–575K
13.
Ethnic delineation of primary glioblastoma genome
Harim Koo, Seung Won Choi, Hee Jin Cho, In‐Hee Lee, Doo‐Sik Kong, Ho Jun Seol, Jung‐Il Lee, Jung‐Won Choi, Jason K. Sa, Do‐Hyun Nam
Cancer Med. 2020 Oct; 9(19): 7352–7359. Published online 2020 Aug 13. doi: 10.1002/cam4.3370
PMCID:
PMC7541127
ArticlePDF–456K
14.
Total DNA methylation as a biomarker of DNA damage and tumor malignancy in intracranial meningiomas
Anna-Maria Barciszewska
BMC Cancer. 2020; 20: 509. Published online 2020 Jun 3. doi: 10.1186/s12885-020-06982-3
PMCID:
PMC7268775
ArticlePDF–1.6M
15.
Molecular Profiling of Primary Central Nervous System Lymphomas – Predictive and prognostic value?
K. Grace Ho, Christian Grommes
Curr Opin Neurol. Author manuscript; available in PMC 2020 Dec 1.
Published in final edited form as: Curr Opin Neurol. 2019 Dec; 32(6): 886–894. doi: 10.1097/WCO.0000000000000759
PMCID:
PMC7141780
ArticlePDF–149K
16.
Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches
Otília Menyhárt, Balázs Győrffy
Cancer Metastasis Rev. 2020; 39(1): 211–233. Published online 2020 Jan 22. doi: 10.1007/s10555-020-09854-1
PMCID:
PMC7098941
ArticlePDF–929K
17.
Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States Are Maintained in 3D Culture
Rochelle C. J. D’Souza, Carolin Offenhäuser, Jasmin Straube, Ulrich Baumgartner, Anja Kordowski, Yuchen Li, Brett W. Stringer, Hamish Alexander, Zarnie Lwin, Po-Ling Inglis, Rosalind L. Jeffree, Terrance G. Johns, Andrew W. Boyd, Bryan W. Day
Cells. 2020 Feb; 9(2): 267. Published online 2020 Jan 21. doi: 10.3390/cells9020267
PMCID:
PMC7072469
ArticlePDF–2.2M
18.
Nivolumab Is Effective in Mismatch Repair–Deficient Noncolorectal Cancers: Results From Arm Z1D—A Subprotocol of the NCI-MATCH (EAY131) Study
Nilofer S. Azad, Robert J. Gray, Michael J. Overman, Jonathan D. Schoenfeld, Edith P. Mitchell, James A. Zwiebel, Elad Sharon, Howard Streicher, Shuli Li, Lisa M. McShane, Larry Rubinstein, David R. Patton, P. Mickey Williams, Brent Coffey, Stanley R. Hamilton, Nathan Bahary, J. Marie Suga, Hassan Hatoum, Jeffrey S. Abrams, Barbara A. Conley, Carlos L. Arteaga, Lyndsay Harris, Peter J. O'Dwyer, Alice P. Chen, Keith T. Flaherty
J Clin Oncol. 2020 Jan 20; 38(3): 214–222. Published online 2019 Nov 25. doi: 10.1200/JCO.19.00818
PMCID:
PMC6968795
ArticlePDF–912K
19.
O6-methylguanine-DNA methyltransferase promoter methylation and isocitrate dehydrogenase mutation as prognostic factors in a cohort of Saudi patients with glioblastoma
Ali H. Alassiri, Ali Alkhaibary, Saud Al-Sarheed, Fahd Alsufani, Mohammed Alharbi, Ahmed Alkhani, Ahmed Aloraidi
Ann Saudi Med. November-December 2019; 39(6): 410-416. Published online 2019 Dec 5. doi: 10.5144/0256-4947.2019.410
PMCID:
PMC6894451
ArticlePDF–401K
20.
Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM
Elizabeth C. Matheson, Huw Thomas, Marian Case, Helen Blair, Rosanna K. Jackson, Dino Masic, Gareth Veal, Chris Halsey, David R. Newell, Josef Vormoor, Julie A.E. Irving
Haematologica. 2019 Sep; 104(9): 1804–1811. Prepublished online 2019 Jan 17. doi: 10.3324/haematol.2017.185975
PMCID:
PMC6717586
ArticlePDF–1007K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center